Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.6790
+0.0184 (2.79%)
Oct 2, 2026, 2:39 PM EDT - Market open
Envoy Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.21 | 0.24 | 0.23 | 0.32 | 0.24 | 0.31 | |
Revenue Growth | -6.76% | 7.11% | -28.80% | 33.33% | -23.55% | - |
Cost of Revenue | 0.82 | 0.68 | 0.74 | 0.79 | 0.5 | 0.77 |
Gross Profit | -0.61 | -0.44 | -0.52 | -0.47 | -0.26 | -0.46 |
Selling, General & Admin | 8.8 | 9.15 | 8.56 | 8.93 | 3.47 | 2.47 |
Research & Development | 14.03 | 12.49 | 10.18 | 8.96 | 4.98 | 3.94 |
Operating Expenses | 22.82 | 21.64 | 18.74 | 17.89 | 8.45 | 6.41 |
Operating Income | -23.43 | -22.08 | -19.26 | -18.36 | -8.71 | -6.87 |
Interest Expense | -0.47 | -1.59 | -0.82 | - | - | - |
Other Non Operating Income (Expenses) | 0.69 | 0.1 | -0.72 | 1.77 | -0.13 | -1.8 |
EBT Excluding Unusual Items | -23.21 | -23.57 | -20.8 | -16.59 | -8.83 | -8.67 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0 |
Other Unusual Items | -0.19 | -0.19 | - | -13.33 | -7.09 | - |
Pretax Income | -23.4 | -23.76 | -20.8 | -29.92 | -15.92 | -8.68 |
Net Income | -23.4 | -23.76 | -20.8 | -29.92 | -15.92 | -8.68 |
Preferred Dividends & Other Adjustments | 5.06 | 4.91 | 7.18 | 1.35 | - | - |
Net Income to Common | -28.46 | -28.66 | -27.97 | -31.27 | -15.92 | -8.68 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 56 | 23 | 19 | 12 | 10 | 10 |
Shares Outstanding (Diluted) | 56 | 23 | 19 | 12 | 10 | 10 |
Shares Change | 177.04% | 23.78% | 52.83% | 21.46% | -0.04% | - |
EPS (Basic) | -0.51 | -1.23 | -1.49 | -2.54 | -1.57 | -0.86 |
EPS (Diluted) | -0.51 | -1.23 | -1.49 | -2.54 | -1.57 | -0.86 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -21.71 | -18.38 | -18.93 | -17.24 | -9.02 | -7.06 |
Free Cash Flow Per Share | -0.39 | -0.79 | -1.01 | -1.40 | -0.89 | -0.70 |
Gross Margin | -293.72% | -183.82% | -229.78% | -149.68% | -110.13% | -148.06% |
Operating Margin | -11319.32% | -9161.83% | -8558.22% | -5809.81% | -3673.42% | -2216.45% |
Profit Margin | -13747.34% | -11892.95% | -12432.44% | -9895.89% | -6718.56% | -2798.39% |
Free Cash Flow Margin | -10488.41% | -7626.56% | -8412.89% | -5456.96% | -3807.17% | -2277.74% |
EBITDA | -23.13 | -21.78 | -19.08 | -18.23 | -8.63 | -6.8 |
D&A For EBITDA | 0.3 | 0.3 | 0.17 | 0.13 | 0.08 | 0.07 |
EBIT | -23.43 | -22.08 | -19.26 | -18.36 | -8.71 | -6.87 |